Lacosamide Versus Propranolol in Episodic Migraine, a Randomized Controlled Double-blinded Trial - PubMed
4 hours ago
- #Propranolol
- #Migraine
- #Lacosamide
- Study compares lacosamide and propranolol for episodic migraine prevention.
- Lacosamide may inhibit CGRP release, aiding migraine management.
- 574 patients completed the randomized, double-blinded trial.
- No significant difference in migraine day reduction between groups.
- Lacosamide 50 mg twice daily showed comparable efficacy to propranolol 80 mg twice daily.
- Both treatments were well-tolerated by patients.
- Study approved by Kafr El-sheikh University ethical committee.